Filipa Lynce
Dana-Farber Cancer Institute

Last Updated On 12/2/2023 3:28:50 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.

Employment
No Relationships to Disclose

Leadership
No Relationships to Disclose

Stock and Other Ownership Interests
No Relationships to Disclose

Honoraria
No Relationships to Disclose

Consulting or Advisory Role
Company: AstraZeneca
Recipient: You
Company: Daiichi Sankyo/Astra Zeneca
Recipient: You
Company: AmerisourceBergen
Recipient: You
Company: Pfizer
Recipient: You
Company: Prime Education
Recipient: You
Company: Eli Lilly
Recipient: You

Speakers' Bureau
No Relationships to Disclose

Research Funding
Company: Bristol-Myers Squibb
Recipient: You
Company: Immunomedics
Recipient: Your Institution
Company: Inivata
Recipient: Your Institution
Company: AstraZeneca/Daiichi Sankyo
Recipient: Your Institution
Company: CytomX Therapeutics
Recipient: Your Institution

Patents, Royalties, Other Intellectual Property
No Relationships to Disclose

Expert Testimony
No Relationships to Disclose

Travel, Accommodations, Expenses
No Relationships to Disclose

Other Relationship
No Relationships to Disclose

(OPTIONAL) Uncompensated Relationships
No Relationships to Disclose

(OPTIONAL) Open Payments Link
Open Payments URL: https://openpaymentsdata.cms.gov/physician/1313721